News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA     7/21/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis     6/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS)     5/9/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug     3/21/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016

News from Around the Web
Fake Painkillers Laced With A Legal Drug 50 Times Stronger Than Heroin     8/16/2017
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock     5/23/2017
3 Revolutionary Drugs for Chronic Pain     3/31/2017
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio     2/10/2017
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016

Press Releases
FDA Turns Down Intellipharmaceutics (IPCI)'s Opiod Painkiller Rexista     9/25/2017
Perrigo (PRGO) Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets     9/21/2017
Millennium Health Release: New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence Of Non-Prescribed Fentanyl     9/21/2017
Elite Pharma (ELI) Files ANDA For Oxycodone Hydrochloride Extended Release     9/20/2017
Braeburn Pharma Announces FDA Acceptance With Priority Review Of New Drug Application For CAM2038 Buprenorphine Depot For The Treatment Of Opioid Use Disorder     9/18/2017
Camurus Announces That FDA Grants Priority Review Of NDA For Weekly And Monthly CAM2038 Buprenorphine Depots For Treatment Of Opioid Use Disorder     9/18/2017
Levicept Starts First-In-Human Phase I Trial Of LEVI-04, A Novel Fusion Protein Therapy For Chronic Pain     9/15/2017
KemPharm (KMPH) Announces FDRR Process Completion And Resubmission Of The Apadaz NDA     9/12/2017
CB Scientific Secures The Intellectual Patent Rights For Pain-Patchtm, A Cannabinoid Pain Alleviation Technology     9/12/2017
Nuvectra (NVTR) Release: First Spinal Cord Stimulator Implant Placed In Northern California By Dr. Goldthwaite Brings Pain Relief And Reduces Opioid Use For Local Injured Veteran     9/11/2017
Nektar (NKTR) Presents Clinical Data From Phase III SUMMIT-07 Study Of NKTR-181, A First-In-Class Investigational Opioid To Treat Chronic Pain, At 2017 PAINWeek     9/7/2017
B.Braun Medical To Showcase At AANA Innovative Portfolio Of Products Designed To Help Optimize Regional Anesthesia     9/7/2017
AbbVie (ABBV) Submits New Drug Application To U.S. FDA For Investigational Oral Treatment Elagolix For The Management Of Endometriosis With Associated Pain     9/6/2017
Daiichi Sankyo Announces Positive Top-Line Results From Phase III Clinical Trial Evaluating Mirogabalin In Diabetic Peripheral Neuropathic Pain     8/31/2017
Aquinox (AQXP) Statement On FDA Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome     8/28/2017